Cost-Per-Responder Analysis of Bimekizumab (IL-17A/F inhibitor) against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, based on Matching-Adjusted Indirect Comparisons (MAIC)
Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons (MAIC)
Recommendations for effective patient involvement in the assessment of medical devices
Budget Impact Analysis of a Solution for Sealant in Spain
An ideal and sustainable framework agreement for the public procurement of vaccines in Spain
Recommendations from the RET-A Think Tank for the management and implementation of advanced therapies in Spain
Budget IMPACT Analysis of LESS Invasive Surfactant Administration (LISA) Technique As EARLY Rescue Strategy for Preterm Infants with Respiratory Distress Syndrome in Spain
A systematic review of economic evaluations in non-insulin antidiabetic treatments for patients with type 2 Diabetes Mellitus
Budget impact analysis of low-dose methoxyflurane for the treatment of moderate-to-severe trauma pain in conscious adult patients in Spain
Cost-Utility Analysis of the germline BRCA testing in Women with epithelial ovarian cancer without family history in Spain
